E
DCPH

Ergoteles’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Ergoteles’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,309
Closed -$230K – 934
2023
Q2 		$230K Buy
+16,309
New +$233K 0.01% 831
2022
Q3 		– Sell
-56,500
Closed -$743K – 2110
2022
Q2 		$743K Buy
56,500
+12,600
+29% +$139K 0.02% 669
2022
Q1 		$407K Buy
43,900
+31,908
+266% +$271K 0.02% 741
2021
Q4 		$117K Sell
11,992
-1,776
-13% -$33.4K ﹤0.01% 1129
2021
Q3 		$468K Buy
+13,768
New +$439K 0.02% 613
2020
Q4 		– Sell
-6,466
Closed -$332K – 956
2020
Q3 		$332K Buy
+6,466
New +$317K 0.04% 317

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's DCPH Position: Q3 2023 in Review

Ergoteles sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 16,309 shares — an estimated $230K sold.

Ergoteles first reported a position in DCPH in Q3 2020 and held it in 6 quarters. The position peaked at $743K in Q2 2022. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Ergoteles reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 16,309 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $230K.
  • Ergoteles first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Ergoteles's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $743K in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.